Tejnaksh Healthcare Ltd (BSE: 539428) is a Dhule, Maharashtra-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹27 Cr, it ranks #4,229 by market cap among the 6,197 Indian listed companies on FinBizNet, and #38 of 46 in Hospitals and Healthcare Centers. At ₹13.79 (as of 16 Nov 2026), the share price is 25.6% below its 52-week high of ₹18.54 and 29.5% above its 52-week low of ₹10.65. The share price is down 19.3% over one year and down 2.9% over three months.
| Current Price | ₹13.79 |
|---|---|
| Market Cap | ₹27 Cr |
| BSE Code | 539428 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 21.8 |
| Return on Equity | 4.37% |
| Return on Assets | 3.17% |
| 52-Week Range | ₹10.65 – ₹18.54 |
| 1-Year Price Change | -19.3% |
| 3-Month Price Change | -2.9% |
| Beta (1Y) | 0.37 |
| Headquarters | Dhule, Maharashtra |
| Website | tejnaksh.com |
Delivery averaged 88.4% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Tejnaksh Healthcare Limited provides hospital and healthcare services in India. The company offers health care services through urology clinics, urology hospitals, and dental super specialty clinics; and operates multi-specialty hospitals, super-specialty hospitals, education institutes, pathology labs, super specialty training institutes, simulation institutes, and stone analysis labs. It also sells healthcare equipment, medical goods, and pharmaceuticals. In addition, the company is involved in the provision of inpatient and outpatient services. Tejnaksh Healthcare Limited was founded in 2003 and is headquartered in Dhule, India.
1. Medical and Healthcare Services-This segment offers healthcare services at urology clinics, urology hospitals, and dental super specialty clinics.
1. Medical and Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| Tejnaksh Healthcare Ltd | ₹27 Cr | 21.8 | 4.37% | — | -19.3% |
Listed by market capitalisation. Ratios are shown for context only.
Tejnaksh Healthcare Ltd is trading at ₹13.79, with a market capitalisation of ₹27 Cr.
Tejnaksh Healthcare Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Tejnaksh Healthcare Ltd has a P/E of 21.8 and a return on equity of 4.37%.
Tejnaksh Healthcare Ltd is listed on the BSE under the scrip code 539428.
Tejnaksh Healthcare Ltd's share price is down 19.3% over one year and down 2.9% over three months. Its 52-week range is ₹10.65 to ₹18.54.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.